Upgrade to SI Premium - Free Trial

FTC Approves Sublicense for Synacthen Depot Submitted by Mallinckrodt ARD Inc. (MNK)

July 14, 2017 2:24 PM
The Federal Trade Commission has approved a sublicense submitted by Mallinckrodt ARD Inc. (NYSE: MNK) granting West Therapeutic Development, LLC ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Litigation Mergers and Acquisitions

Next Articles